高级检索

三维斑点追踪成像技术评估不同剂量蒽环类药物化疗后左心室应变

Evaluation of left ventricular deformation changes in patients underwent different doses of anthracycline chemotherapyusing 3D speckle-tracking imaging

  • 摘要:
    目的 应用超声心动图三维斑点追踪成像(3D speckle-tracking imaging, 3D-STI)技术分析评估采用不同剂量蒽环类药物化疗的弥漫大B细胞淋巴瘤(diffuse large B-cell non-Hodgkin lymphoma, DLBCL)患者的左室形变功能变化。
    方法 纳入接受蒽环类药物化疗的DLBCL患者66例。根据接受蒽环类药物的累积剂量,将患者分为高剂量组(>360 mg/m2n=39)和低剂量组(≤360 mg/m2n=27)。患者分别于化疗前及全部化疗周期结束后1周内行超声心动图检查,应用3D-STI分析左心室整体纵向应变(left ventricular global longitudinal strain, LVGLS)、左心室整体环向应变(left ventricular global circumferential strain, LVGCS)等指标化疗前后的差异,分析不同亚组间的左心应变指标差异及变化率差异。
    结果 与化疗前相比,患者化疗后的LVGLS、LVGCS、左心房纵向应变(left atrial global longitudinal strain,LAGLS)均显著降低(P<0.001)。与低剂量组相比,高剂量组在化疗结束时LVGCS变化率明显增加21.12(6.52,35.37)vs 5.49(﹣14.73,27.01);P=0.03。而两亚组之间患者的左室射血分数(left ventricular ejection fraction,LVEF)、LVGLS、LVGCS、LVEF变化率及LVGLS变化率等参数差异无统计学意义。
    结论 3D-STI在评价肿瘤患者蒽环类药物治疗后,早期左室功能的亚临床改变有一定的临床参考价值;LVGCS变化率可作为预测高低剂量蒽环类药物治疗后心脏功能亚临床变化差别的辅助指标。

     

    Abstract:
    Objective To analyze the changes in left ventricular deformation function in patients with diffuse large B-cell lymphoma (DLBCL) treated with different doses of anthracycline chemotherapy using 3D speckle-tracking imaging (3D-STI).
    Methods 66 DLBCL patients receiving anthracycline chemotherapy were enrolled. Based on the cumulative dose of anthracycline received, the patients were divided into a high-dose group (> 360 mg/m2, n=39) and a low-dose group (≤360 mg/m2, n=27). Patients underwent transthoracic echocardiography before chemotherapy and within one week after completion of the entire chemotherapy cycle. Left ventricular global longitudinal strain (LVGLS), left ventricular global circumferential strain (LVGCS), and other indices were analyzed using 3D-STI to assess changes in left ventricular deformation indices after chemotherapy and between two groups.
    Results Compared to baseline, DLBCL patients showed significant reductions in LVGLS, LVGCS and left atrial global longitudinal strain (LAGLS) after treatment completion (P < 0.001). When comparing the high-dose group with the low-dose group, there was a significant increase in relative LVGCS change rate at the end of chemotherapy (21.12 6.52, 35.37 vs 5.49 ﹣14.73, 27.01; P=0.03). However, there were no statistically significant differences in relative left ventricular ejection fraction (LVEF), LVGLS, LVGCS, LVEF change rate, or LVGLS change rate between the two groups.
    Conclusions 3D-STI can be a potential method to identify the sub-clinical deterioration of left ventricular systolic function in patients received anthracycline chemotherapy, the difference of change rate of LVGCS may predict the variation of sub-clinical deterioration of left ventricular function between patients received high and low doses of anthracycline chemotherapy.

     

/

返回文章
返回